Regeneron Pharmaceuticals REGN

$794.67

−$7.16 (-0.89%)

Market open · Sep 24, 2:00 pm ET

After hours $801.82 0.00%

Open$801.59

Prev close$801.82

Day range$789.41 – $807.21

Volume268.3K

Market cap$81.81B

P/E (TTM)19.7

Dividend yield0.46%

Analysts' Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN), Cytokinetics (CYTK) and Biohaven Ltd. (BHVN) TipRanks · 10 Sep 2026
HSBC Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Raises Target Price to $920 Market news · 10 Sep 2026
LYC Healthcare: MEXTER TECHNOLOGY BERHAD (MEXTER) â€¢ PROPOSED ACQUISITION BY ITS 80% OWNED SUBSIDIARY MEXCOMM SDN BHD (777810-D) OF A 49% EQUITY INTEREST IN E-G6 SOLUTION (THAILAND) CO. LTD. (REGN NO. 0105551096920) (â€œTHE COMPANYâ€) (â€œACQUISITIONâ€ Bursa Malaysia · 6 Aug 2026
J.P. Morgan Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Raises Target Price to $900 Market news · 5 Aug 2026
Barclays Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $917 Market news · 5 Aug 2026
Guggenheim Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Raises Target Price to $1,030 Market news · 3 Aug 2026
Leerink Partners Downgrades Regeneron Pharmaceuticals(REGN.US) to Hold Rating, Announces Target Price $824 Market news · 17 Aug 2026
A Quick Look at Today's Ratings for Regeneron Pharmaceuticals(REGN.US), With a Forecast Between $750 to $960 Market news · 31 Jul 2026
CCORF Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $875 Market news · 22 Jul 2026